Clinical trial
BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not…
NCT00004927 · R-Pharm, Industry · Completed
Key facts
| NCT number | NCT00004927 |
|---|---|
| Title | BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy |
| Official title | Phase I Study of BMS-247550 Given Every Three Weeks in Patients With Advanced Malignancies |
| Lead sponsor | R-Pharm, Industry |
| Collaborators | National Cancer Institute (NCI) NIH Memorial Sloan Kettering Cancer Center |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | ixabepilone |
| Start date | Jul 1, 1999 |
| Primary completion | Oct 1, 2002 |
| Completion | Oct 1, 2002 |
| First posted | Jun 4, 2004 |
| Last update posted | Jan 30, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: